{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:32:04Z","timestamp":1789093924426,"version":"build-2803163510"},"reference-count":47,"publisher":"The Company of Biologists","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"am","delay-in-days":1598,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["1DP3DK094292"],"award-info":[{"award-number":["1DP3DK094292"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["1R24082841"],"award-info":[{"award-number":["1R24082841"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["5K01NS079461"],"award-info":[{"award-number":["5K01NS079461"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["5-R24-DK-082941"],"award-info":[{"award-number":["5-R24-DK-082941"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["T32 AG000114"],"award-info":[{"award-number":["T32 AG000114"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["T32 NS007222"],"award-info":[{"award-number":["T32 NS007222"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Program for Neurology Research & Discovery"},{"DOI":"10.13039\/100008456","name":"A. Alfred Taubman Medical Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008456","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Patients with the metabolic syndrome, defined as obesity, dyslipidemia, hypertension, and impaired glucose tolerance (IGT), can develop the same macro- and microvascular complications as patients with type 2 diabetes, including peripheral neuropathy. In type 2 diabetes, glycemic control has little effect on the development and progression of peripheral neuropathy, suggesting that other metabolic syndrome components may contribute to the presence of neuropathy. A parallel phenomenon is observed in patients with prediabetes and the metabolic syndrome, where improvement in weight and dyslipidemia more closely correlates with restoration of nerve function than improvement in glycemic status. The goal of the current study was to develop a murine model that resembles the human condition. We examined longitudinal parameters of the metabolic syndrome and neuropathy development in six mouse strains\/genotypes (BKS-wt, BKS-Leprdb\/+, B6-wt, B6-Leprdb\/+, BTBR-wt, and BTBR-Lepob\/+) fed a 54% high-fat diet (HFD; from lard). All HFD-fed mice developed large fiber neuropathy and IGT. Changes appeared early and consistently in B6-wt mice, and paralleled the onset of neuropathy. Terminally, B6-wt mice displayed all components of the metabolic syndrome, including obesity, IGT, hyperinsulinemia, dyslipidemia, and oxidized low density lipoproteins (oxLDL). Dietary reversal, whereby B6-wt mice fed HFD from 4-20 weeks of age were switched to standard chow for 4 weeks, completely normalized neuropathy, promoted weight loss, improved insulin sensitivity, and restored LDL-cholesterol and oxLDL by 50% compared to HFD control mice. This dietary reversal model provides the basis for mechanistic studies investigating peripheral nerve damage in the setting of the metabolic syndrome, and ultimately the development of mechanism-based therapies for neuropathy.<\/jats:p>","DOI":"10.1242\/dmm.028530","type":"journal-article","created":{"date-parts":[[2017,4,6]],"date-time":"2017-04-06T00:40:33Z","timestamp":1491439233000},"source":"Crossref","is-referenced-by-count":39,"title":["Dietary reversal of neuropathy in a murine model of prediabetes and the metabolic syndrome"],"prefix":"10.1242","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5206-8010","authenticated-orcid":false,"given":"Lucy M.","family":"Hinder","sequence":"first","affiliation":[{"name":"Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillipe D.","family":"O'Brien","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Hayes","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carey","family":"Backus","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Solway","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catrina","family":"Sims-Robinson","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of South Carolina, Charleston, SC, 29425, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9162-2694","authenticated-orcid":false,"given":"Eva L.","family":"Feldman","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","published-online":{"date-parts":[[2017,1,1]]},"reference":[{"key":"2021042500135178200_DMM028530C1","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1242\/dmm.015750","article-title":"Role of insulin signaling impairment, adiponectin and dyslipidemia in peripheral and central neuropathy in mice","volume":"7","author":"Anderson","year":"2014","journal-title":"Dis. Model. Mech."},{"key":"2021042500135178200_DMM028530C2","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1042\/BST0331041","article-title":"Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?","volume":"33","author":"Biessels","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"2021042500135178200_DMM028530C3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-2999(02)01486-3","article-title":"Ageing and diabetes: implications for brain function","volume":"441","author":"Biessels","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"2021042500135178200_DMM028530C4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/jns5.12072","article-title":"Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab)","volume":"19","author":"Biessels","year":"2014","journal-title":"J. Peripher. Nerv. Syst."},{"key":"2021042500135178200_DMM028530C5","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.2337\/diacare.27.6.1458","article-title":"Diabetic somatic neuropathies","volume":"27","author":"Boulton","year":"2004","journal-title":"Diabetes Care"},{"key":"2021042500135178200_DMM028530C6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","article-title":"Diabetic neuropathy: clinical manifestations and current treatments","volume":"11","author":"Callaghan","year":"2012","journal-title":"Lancet Neurol."},{"key":"2021042500135178200_DMM028530C7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/WCO.0b013e328357a797","article-title":"Diabetic neuropathy: one disease or two?","volume":"25","author":"Callaghan","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"2021042500135178200_DMM028530C8","doi-asserted-by":"publisher","first-page":"CD007543","DOI":"10.1002\/14651858.cd007543.pub2","article-title":"Enhanced glucose control for preventing and treating diabetic neuropathy","volume":"6","author":"Callaghan","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"2021042500135178200_DMM028530C9","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1001\/jama.2015.13611","article-title":"Distal symmetric polyneuropathy: a review","volume":"314","author":"Callaghan","year":"2015","journal-title":"JAMA"},{"key":"2021042500135178200_DMM028530C10","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2337\/dc16-0081","article-title":"Metabolic syndrome components are associated with symptomatic polyneuropathy independent of glycemic status","volume":"39","author":"Callaghan","year":"2016","journal-title":"Diabetes Care"},{"key":"2021042500135178200_DMM028530C11","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1001\/jamaneurol.2016.3745","article-title":"Association between metabolic syndrome components and polyneuropathy in an obese population","volume":"73","author":"Callaghan","year":"2016","journal-title":"JAMA Neurol."},{"key":"2021042500135178200_DMM028530C12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.nbd.2011.08.011","article-title":"Nerve growth factor\/p38 signaling increases intraepidermal nerve fiber densities in painful neuropathy of type 2 diabetes","volume":"45","author":"Cheng","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"2021042500135178200_DMM028530C13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/B978-0-444-53480-4.00009-6","article-title":"Glucose intolerance, metabolic syndrome, and neuropathy","volume":"126","author":"Cortez","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"2021042500135178200_DMM028530C14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/ilar.43.4.244","article-title":"Guidelines for the design and statistical analysis of experiments using laboratory animals","volume":"43","author":"Festing","year":"2002","journal-title":"ILAR J."},{"key":"2021042500135178200_DMM028530C15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"2021042500135178200_DMM028530C16","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1016\/j.pain.2013.07.052","article-title":"Exercise-mediated improvements in painful neuropathy associated with prediabetes in mice","volume":"154","author":"Groover","year":"2013","journal-title":"Pain"},{"key":"2021042500135178200_DMM028530C111","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13136","article-title":"Comparative RNA-Seq transcriptome analyses reveal distinct metabolic pathways in diabetic nerve and kidney disease","author":"Hinder","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"2021042500135178200_DMM028530C17","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.2337\/db15-0133","article-title":"The metabolic syndrome and microvascular complications in a murine model of type 2 diabetes","volume":"64","author":"Hur","year":"2015","journal-title":"Diabetes"},{"key":"2021042500135178200_DMM028530C18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1161\/CIRCULATIONAHA.104.511964","article-title":"Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy","volume":"112","author":"Ii","year":"2005","journal-title":"Circulation"},{"key":"2021042500135178200_DMM028530C19","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/NEN.0b013e3182580673","article-title":"Glucagon-like peptide 1, insulin, sensory neurons, and diabetic neuropathy","volume":"71","author":"Kan","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2021042500135178200_DMM028530C20","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jdiacomp.2012.05.007","article-title":"The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy","volume":"26","author":"Kluding","year":"2012","journal-title":"J. Diabetes Complications"},{"key":"2021042500135178200_DMM028530C21","doi-asserted-by":"publisher","first-page":"15333","DOI":"10.1074\/jbc.M110.100263","article-title":"Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice","volume":"285","author":"Li","year":"2010","journal-title":"J. Biol. Chem."},{"key":"2021042500135178200_DMM028530C22","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s11883-004-0030-9","article-title":"Antidiabetic actions of estrogen: insight from human and genetic mouse models","volume":"6","author":"Louet","year":"2004","journal-title":"Curr. Atheroscler Rep."},{"key":"2021042500135178200_DMM028530C23","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1172\/JCI57132","article-title":"Inflammatory links between obesity and metabolic disease","volume":"121","author":"Lumeng","year":"2011","journal-title":"J. Clin. Invest."},{"key":"2021042500135178200_DMM028530C24","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.bbr.2006.09.010","article-title":"Longitudinal study of the effects of a high-fat diet on glucose regulation, hippocampal function, and cerebral insulin sensitivity in C57BL\/6 mice","volume":"175","author":"Mielke","year":"2006","journal-title":"Behav. Brain Res."},{"key":"2021042500135178200_DMM028530C25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/2046-2395-2-10","article-title":"High saturated fat and low carbohydrate diet decreases lifespan independent of body weight in mice","volume":"2","author":"Muller","year":"2013","journal-title":"Longev Healthspan"},{"key":"2021042500135178200_DMM028530C26","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.nbd.2014.10.015","article-title":"BTBR ob\/ob mice as a novel diabetic neuropathy model: neurological characterization and gene expression analyses","volume":"73C","author":"O'Brien","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"2021042500135178200_DMM028530C27","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/ilar\/ilt052","article-title":"Mouse models of diabetic neuropathy","volume":"54","author":"O'Brien","year":"2014","journal-title":"ILAR J."},{"key":"2021042500135178200_DMM028530C28","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.2337\/db06-1176","article-title":"High-fat diet induced neuropathy of pre-diabetes and obesity: effects of \u201chealthy\u201d diet and aldose reductase inhibition","volume":"56","author":"Obrosova","year":"2007","journal-title":"Diabetes"},{"key":"2021042500135178200_DMM028530C29","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1001\/jama.2014.732","article-title":"Prevalence of childhood and adult obesity in the United States, 2011-2012","volume":"311","author":"Ogden","year":"2014","journal-title":"JAMA"},{"key":"2021042500135178200_DMM028530C30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.neulet.2010.07.076","article-title":"The effects of anesthesia on measures of nerve conduction velocity in male C57Bl6\/J mice","volume":"483","author":"Oh","year":"2010","journal-title":"Neurosci. Lett."},{"key":"2021042500135178200_DMM028530C31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/B978-0-12-411619-1.00006-9","article-title":"Quantifying size and number of adipocytes in adipose tissue","volume":"537","author":"Parlee","year":"2014","journal-title":"Methods Enzymol."},{"key":"2021042500135178200_DMM028530C32","doi-asserted-by":"publisher","first-page":"e46057","DOI":"10.1371\/journal.pone.0046057","article-title":"Female mice are protected against high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue","volume":"7","author":"Pettersson","year":"2012","journal-title":"PLoS ONE"},{"key":"2021042500135178200_DMM028530C33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1006\/nbdi.1999.0254","article-title":"Neurons undergo apoptosis in animal and cell culture models of diabetes","volume":"6","author":"Russell","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"2021042500135178200_DMM028530C34","doi-asserted-by":"publisher","first-page":"E1495","DOI":"10.1152\/ajpendo.00366.2013","article-title":"Divergent compensatory responses to high-fat diet between C57BL6\/J and C57BLKS\/J inbred mouse strains","volume":"305","author":"Sims","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2021042500135178200_DMM028530C35","doi-asserted-by":"publisher","first-page":"e0163883","DOI":"10.1371\/journal.pone.0163883","article-title":"Dietary reversal ameliorates short- and long-term memory deficits induced by high-fat diet early in life","volume":"11","author":"Sims-Robinson","year":"2016","journal-title":"PLoS ONE"},{"key":"2021042500135178200_DMM028530C36","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/ana.24310","article-title":"Supervised exercise improves cutaneous reinnervation capacity in metabolic syndrome patients","volume":"77","author":"Singleton","year":"2015","journal-title":"Ann. Neurol."},{"key":"2021042500135178200_DMM028530C37","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s11892-015-0682-6","article-title":"Exercise as therapy for diabetic and prediabetic neuropathy","volume":"15","author":"Singleton","year":"2015","journal-title":"Curr. Diab Rep."},{"key":"2021042500135178200_DMM028530C38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1212\/01.con.0000411568.34085.3e","article-title":"Diabetic neuropathy","volume":"18","author":"Smith","year":"2012","journal-title":"Continuum (Minneap Minn)"},{"key":"2021042500135178200_DMM028530C39","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jdiacomp.2013.04.003","article-title":"Obesity and hyperlipidemia are risk factors for early diabetic neuropathy","volume":"27","author":"Smith","year":"2013","journal-title":"J. Diabetes Complications"},{"key":"2021042500135178200_DMM028530C40","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.2337\/dc06-0224","article-title":"Lifestyle intervention for pre-diabetic neuropathy","volume":"29","author":"Smith","year":"2006","journal-title":"Diabetes Care"},{"key":"2021042500135178200_DMM028530C41","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","article-title":"Prediabetes: a high-risk state for diabetes development","volume":"379","author":"Tab\u00e1k","year":"2012","journal-title":"Lancet"},{"key":"2021042500135178200_DMM028530C42","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.2337\/dc10-1303","article-title":"Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments","volume":"33","author":"Tesfaye","year":"2010","journal-title":"Diabetes Care"},{"key":"2021042500135178200_DMM028530C43","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.2337\/db09-0047","article-title":"Dyslipidemia-induced neuropathy in mice: the role of oxLDL\/LOX-1","volume":"58","author":"Vincent","year":"2009","journal-title":"Diabetes"},{"key":"2021042500135178200_DMM028530C44","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.neuroscience.2011.07.039","article-title":"Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice","volume":"193","author":"Wang","year":"2011","journal-title":"Neuroscience"},{"key":"2021042500135178200_DMM028530C45","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.2337\/db08-1771","article-title":"elevated triglycerides correlate with progression of diabetic neuropathy","volume":"58","author":"Wiggin","year":"2009","journal-title":"Diabetes"},{"key":"2021042500135178200_DMM028530C46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/jns.12111","article-title":"Effect of diet-induced obesity or type 1 or type 2 diabetes on corneal nerves and peripheral neuropathy in C57Bl\/6J mice","volume":"20","author":"Yorek","year":"2015","journal-title":"J. Peripher. Nerv. Syst."}],"container-title":["Disease Models &amp; Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1242\/dmm.028530","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/journals.biologists.com\/dmm\/article-pdf\/10\/6\/717\/1860698\/dmm028530.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.028530\/2069331\/dmm_028530v1.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.028530\/2069331\/dmm_028530v1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T21:55:44Z","timestamp":1621374944000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/dmm\/article\/doi\/10.1242\/dmm.028530\/257153\/Dietary-reversal-of-neuropathy-in-a-murine-model"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,1]]},"references-count":47,"URL":"https:\/\/doi.org\/10.1242\/dmm.028530","relation":{},"ISSN":["1754-8411","1754-8403"],"issn-type":[{"value":"1754-8411","type":"electronic"},{"value":"1754-8403","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1,1]]},"article-number":"dmm.028530"}}